67 results on '"Reinhard Berner"'
Search Results
2. Comparing SARS-CoV-2 variants among children and adolescents in Germany: relative risk of COVID-19-related hospitalization, ICU admission and mortality
- Author
-
Marietta Jank, Anna-Lisa Oechsle, Jakob Armann, Uta Behrends, Reinhard Berner, Cho-Ming Chao, Natalie Diffloth, Maren Doenhardt, Gesine Hansen, Markus Hufnagel, Fabian Lander, Johannes G. Liese, Ania C. Muntau, Tim Niehues, Ulrich von Both, Eva Verjans, Katharina Weil, Rüdiger von Kries, and Horst Schroten
- Subjects
Microbiology (medical) ,Infectious Diseases ,General Medicine - Abstract
Purpose SARS-CoV-2 infections cause COVID-19 and have a wide spectrum of morbidity. Severe disease courses among children are rare. To date, data on the variability of morbidity in relation to variant of concern (VOC) in children has been sparse and inconclusive. We compare the clinical severity of SARS-CoV-2 infection among children and adolescents in Germany during the Wildtype and Alpha combined, Delta and Omicron phases of the COVID-19 pandemic. Methods Comparing risk of COVID-19-related hospitalization, intensive care unit (ICU) admission and death due to COVID-19 in children and adolescents, we used: (1) a multi-center seroprevalence study (SARS-CoV-2-KIDS study); (2) a nationwide registry of pediatric patients hospitalized with SARS-CoV-2 infections; and (3) compulsory national reporting for RT-PCR-confirmed SARS-CoV-2 infections in Germany. Results During the Delta predominant phase, risk of COVID-19-related hospitalization among all SARS-CoV-2 seropositive children was 3.35, ICU admission 1.19 and fatality 0.09 per 10,000; hence about halved for hospitalization and ICU admission and unchanged for deaths as compared to the Wildtype- and Alpha-dominant period. The relative risk for COVID-19-related hospitalization and ICU admission compared to the alpha period decreased during Delta [0.60 (95% CI 0.54; 0.67) and 0.51 (95% CI 0.42; 0.61)] and Omicron [0.27 (95% CI 0.24; 0.30) and 0.06 (95% CI 0.05; 0.08)] period except for the Conclusion Morbidity caused by SARS-CoV-2 infections among children and adolescents in Germany decreased over the course of the COVID-19 pandemic, as different VOCs) emerged.
- Published
- 2023
3. Kinder und Jugendliche auf der Flucht
- Author
-
Reinhard Berner
- Subjects
Pediatrics, Perinatology and Child Health ,Surgery - Published
- 2022
4. Aktuelle Projekte der versorgungsorientierten pädiatrischen Forschung
- Author
-
Fred Zepp, Reinhard Berner, Gesine Hansen, and Reinhold Kerbl
- Subjects
Pediatrics, Perinatology and Child Health ,Surgery - Published
- 2022
5. Seroprevalence of SARS-CoV-2 in German secondary schools from October 2020 to July 2021: a longitudinal study
- Author
-
Carolin Kirsten, Elisabeth Kahre, Judith Blankenburg, Leonie Schumm, Luise Haag, Lukas Galow, Manja Unrath, Paula Czyborra, Josephine Schneider, Christian Lück, Alexander H. Dalpke, Reinhard Berner, and Jakob Armann
- Subjects
Microbiology (medical) ,Schools ,Infectious Diseases ,Adolescent ,SARS-CoV-2 ,Seroepidemiologic Studies ,Communicable Disease Control ,Humans ,COVID-19 ,Longitudinal Studies ,General Medicine ,Child - Abstract
Purpose To quantify the number of SARS-CoV-2 infections in students and teachers in 14 Secondary schools in eastern Saxony, Germany. Seroprevalence of SARS-CoV-2 antibodies in study population. Number of undetected cases. Methods Serial seroprevalence study. Results The role of educational settings in the SARS-CoV-2 Pandemic is still controversial. Seroprevalence increases from 0.8 to 5.9% from October to December when schools remained open and to 12.2% in March/April during a strict lockdown with closed schools. The ratio of undetected to detected cases decreased from 0.76 to 0.44 during the study period. Conclusion During the second and third wave of the pandemic in Germany, students and teachers are not overrepresented in SARS-CoV-2 infections. The percentage of undetected cases is moderate and decreases over time. The risk of contracting SARS-CoV-2 within the household is higher than contracting it in educational settings making school closures rather ineffective in terms of pandemic control measures or individual risk reduction in children and adolescents. Trial registration DRKS00022455 (July 23rd, 2020).
- Published
- 2022
6. Zwischen asymptomatischer Besiedelung und fulminanter Infektion
- Author
-
Nicole Töpfner and Reinhard Berner
- Published
- 2022
7. SARS-CoV-2 in pediatric cancer: a systematic review
- Author
-
Sandy Schlage, Thomas Lehrnbecher, Reinhard Berner, Arne Simon, and Nicole Toepfner
- Subjects
Pediatric ,Adolescent ,SARS-CoV-2 ,COVID-19 ,Malignancy ,Review ,Disease Outbreaks ,Neoplasms ,Pediatrics, Perinatology and Child Health ,Humans ,Chemotherapy ,Child ,Pandemics ,Cancer - Abstract
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019 in Wuhan challenges pediatric oncologists in an unexpected way. We provide a comprehensive overview, which systematically summarizes and grades evidence (QoE) on SARS-CoV-2 infections in pediatric cancer patients at 1.5 years of pandemic. A systematic literature search in PubMed combined with an additional exploratory literature review in other international databases was conducted to identify studies on children (aged Conclusion: Despite a favorable COVID-19 outcome in most pediatric cancer patients, the morbidity is reported higher than in children without comorbidities. However, no severe COVID-19 complications were associated to the continuation of chemotherapy in some cohort studies and reports on two patients. Therefore, the risk of cancer progress or relapse due to interruption of chemotherapy has carefully to be weighed against the risk of severe COVID-19 disease with potentially fatal outcome. What is Known:• Most of pediatric patients with malignant diseases show an asymptomatic, mild or moderate clinical course of SARS-CoV-2 infection. • Current need for a basis for decision-making, whether to stop or interrupt cancer treatment in a patient infected with SARS-CoV-2, and when to continue chemotherapy. What is New:• Review results comprising over 1000 pediatric COVID-19 cancer patients confirm mild courses of SARS-CoV-2 infection in most patients but also show the attributable mortality is at least 10 times higher compared to reports on hospitalized children without comorbidities.• Review identifies that chemotherapy was continued despite SARS-CoV-2 positivity in 18% of patients with individual chemotherapy modification according to the clinical course of SARS-CoV-2 infection and existing comorbidities. On this basis, no severe COVID-19 complications were associated to the continuation of chemotherapy in several cohort studies and two case reports.
- Published
- 2022
8. Der klinische Versorgungspfad zur multiprofessionellen Versorgung seltener Erkrankungen in der Pädiatrie – Ergebnisse aus dem Projekt TRANSLATE-NAMSE
- Author
-
Daniela Choukair, Min Ae Lee-Kirsch, Reinhard Berner, Corinna Grasemann, Olaf Hiort, Fabian Hauck, Christoph Klein, Diana Druschke, Georg F. Hoffmann, and Peter Burgard
- Subjects
Pediatrics, Perinatology and Child Health ,Surgery - Abstract
Zusammenfassung Hintergrund Seltene Erkrankungen (SE) manifestieren sich ganz überwiegend im Kindes- und Jugendalter, sind heterogen, multisystemisch, haben meist einen chronischen Verlauf und stellen eine große Herausforderung für alle Beteiligten dar. Finanziert durch den Innovationsfonds des G‑BA hatte das Versorgungsprojekt TRANSLATE-NAMSE das Ziel, Vorschläge zur besseren Versorgung von Menschen mit SE zu entwickeln und zu erproben. Fragestellung Für Patienten aller Altersgruppen mit einer Verdachtsdiagnose aus einer von 5 Gruppen definierter Indikatorerkrankungen (seltene Anämien, Endokrinopathien, Autoinflammationserkrankungen, primäre Immundefekte und Stoffwechselerkrankungen) sollte ein generischer Versorgungspfad entwickelt werden, der den Weg von der Konfirmationsdiagnostik bis hin zur Langzeitbetreuung dieser Patienten abbildet. Methodik Der Versorgungspfad wurde als allgemeines Ablaufschema dargelegt; die Prozessschritte wurden in eine Checkliste übertragen, inhaltlich ausformuliert und an 6 universitären Standorten an 587 Personen mit der Verdachtsdiagnose einer Indikatorerkrankungen erprobt. Ergebnisse Für 369 (62,9 %) Fälle mit der Verdachtsdiagnose einer Indikatorerkrankung konnte eine Diagnose gestellt werden, davon in 25,2 % mit innovativer genetischer Diagnostik; 104 (17,7 %) Verdachtsdiagnosen erwiesen sich als falsch-positiv; 114 (19,4 %) Fälle blieben ungeklärt. An Fallkonferenzen zur multiprofessionellen Versorgung nahmen im Median 4 Spezialisten teil. Die Versorgung (Diagnoseeröffnung, Schulung, Beratung, Information) begann im Median am Tag des Diagnostikergebnisses. In einer externen Evaluation erwies sich die Zufriedenheit der Sorgeberechtigten mit dem Versorgungspfad als hoch. Schlussfolgerungen Im bisher in Deutschland einzigartigen TRANSLATE-NAMSE-Projekt wurde ein Versorgungspfad für SE in der Pädiatrie entwickelt und erfolgreich erprobt. Zur Verstetigung dieser Versorgungsform ist eine auskömmliche Finanzierung in der Regelversorgung anzustreben.
- Published
- 2021
9. Resource consumption of a structured transition of young people with rare diseases from pediatric to adult care in a German nationwide cohort : Effort and cost analysis from the TRANSLATE-NAMSE project
- Author
-
C. Weiler-Normann, G. Müller, J. Höppner, Reinhard Berner, Daniela Choukair, Min Ae Lee-Kirsch, Georg F. Hoffmann, K. Wainwright, Corinna Grasemann, Peter Burgard, N. Matar, and S. Baumgarten
- Subjects
business.industry ,Pediatrics, Perinatology and Child Health ,Medizin ,Medicine ,Surgery ,business ,Humanities - Published
- 2021
10. Restrictive prescription of antibiotics in preterm infants with premature rupture of membranes
- Author
-
Jakob Armann, Mario Rüdiger, Reinhard Berner, and Lars Mense
- Subjects
Prescriptions ,Sepsis ,Pediatrics, Perinatology and Child Health ,Infant, Newborn ,Humans ,Infant, Premature ,Anti-Bacterial Agents ,Retrospective Studies - Abstract
Background In preterm infants with premature rupture of membranes, antibiotic treatment is frequently started but rates of early onset sepsis are lower. In line with national guidelines, a stratified approach in the decision to start antibiotic treatment using maternal history, clinical impression and biomarkers has been implemented in our level III neonatal center and its results are evaluated. Methods Retrospective cohort study of all preterm newborns with rupture of membranes at least 1 h prior to delivery admitted to our tertiary neonatal intensive care unit. Data on antibiotic exposure, mortality and major neonatal complications were extracted from the electronic patient charts to evaluate the effects and safety of our stratified approach. Results Four hundred fifty-six infants met the inclusion criteria. 120 (26%) received primary antibiotics whereas 336 (74%) did not. Of those receiving primary antibiotics, 13 (11%) had a blood culture positive sepsis, 46 (38%) met the criteria of clinical sepsis and in 61 (51%) sepsis was ruled out and antibiotics were stopped after 48-96 h. All infants with blood culture positive sepsis were identified and treated within the first 24 h of life using this approach. None of the 336 infants who were not started on antibiotics primarily needed antibiotic therapy within the first 5 days of life. There were no deaths or major neonatal complications in the group that did not receive empiric antibiotics. Conclusions Our stratified approach for preterm infants with premature rupture of membranes allows a safe reduction of antibiotic exposure even in this high risk population. As a result, only 25% of high risk preterm newborns are treated with antibiotics of which more than half receive less than 5 days of treatment. To treat one infant with blood culture positive sepsis, only 9 infants receive empiric antibiotics.
- Published
- 2022
11. Verwendung von Masken bei Kindern zur Verhinderung der Infektion mit SARS-CoV-2
- Author
-
Reinhard Berner, Matthias Keller, Thomas Fischbach, Hans-Iko Huppertz, Burkhard Rodeck, Matthias V. Kopp, Johannes Hübner, Renate Schepker, Arne Simon, Markus Knuf, and Andreas Oberle
- Subjects
Gynecology ,03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Pediatrics, Perinatology and Child Health ,Medicine ,Surgery ,030212 general & internal medicine ,business ,030217 neurology & neurosurgery - Abstract
Das Tragen von Masken (Alltagsmaske oder chirurgische Maske) ist neben der Abstandswahrung und Hygienemasnahmen zu einem wesentlichen Mittel zur Eindammung der SARS-CoV-2-Pandemie geworden. Sie stellen eine wesentliche Barriere fur infektiose Tropfchen im Nahfeld dar und konnen neben dem Fremdschutz moglicherweise auch den Trager schutzen. Nach Darstellung moglicher korperlicher oder seelischer Nebenwirkungen bei Erwachsenen werden die wenigen Daten zu unerwunschten Wirkungen bei Kindern referiert. Bei bestimmungsgemaser Anwendung sind bislang keine wesentlichen Nebenwirkungen bekannt geworden. Allerdings konnen Masken sehr lastig sein. Die Schlussfolgerung besagt, dass bei gesunden wachen Kindern, die jederzeit in der Lage sind, die Maske selbststandig abzunehmen, unerwunschte Wirkungen nicht zu befurchten sind. Wahrend Kinder etwa ab 10 Jahren mit einer Maske nach altersgemaser Aufklarung und Demonstration sinnvoll und effektiv umgehen konnen, sodass das Tragen auch vorgeschrieben werden kann, sollten Grundschuler nicht dazu verpflichtet und Vorschulkinder davon befreit werden. Die Tragedauer sollte begrenzt werden, und Schulkinder, die an ihrem Platz unter Einhaltung des Abstandsgebotes sitzen, sollen die Maske abnehmen durfen.
- Published
- 2020
12. Kinder mit akuter Atemwegsinfektion in Kinderkliniken im Herbst/Winter 2020/21
- Author
-
Reinhard Berner, Hans Iko Huppertz, Arne Simon, Johannes Huebner, and Peter Walger
- Subjects
medicine.medical_specialty ,Isolation (health care) ,Respiratory tract infections ,business.industry ,Incidence (epidemiology) ,Public health ,media_common.quotation_subject ,Economic shortage ,Hygiene ,Pediatrics, Perinatology and Child Health ,Medicine ,Infection control ,Surgery ,Cumulative incidence ,business ,Intensive care medicine ,media_common - Abstract
Due to the shortage of pediatric hospital beds in general and due to the large annual burden of hospital admissions for common respiratory tract infections, such as influenza or RSV [respiratory syncytial virus] in particular, it can be expected that hospitalization of children with suspected or confirmed SARS-CoV‑2 infections will face hospitals with an even more tense situation than usual in the winter 2020/2021. This tenuous shortage may touch various aspects but in the first place it will affect isolation and cohorting. In addition, this shortage will not only apply to acutely ill children with viral respiratory tract infections but all children with need for hospital care, either chronically ill or e.g. being premature babies or newborns. Therefore, approaches are required which on the one hand are based on pragmatic grounds but on the other hand fulfill the basics of hygiene and infection control. The recommendations proposed in this statement are intended to give assistance to hospitals for the management of testing, isolation and cohorting of pediatric patients with suspected or confirmed SARS-CoV‑2 infections. The most important factor navigating the essential measures is the cumulative incidence of newly diagnosed infections per 100,000 over the last 7 days, which is given by the RKI or the local public health authorities. In the situation of low ( 50/100,000) incidence the respective diagnostic measures and the admission have to be performed under SARS-CoV‑2 precautions as specified by the RKI, and the children have to be isolated until the results of SARS-CoV‑2 test are available. The assessment of the incidence figures and the respective measures may be adapted by the local public health authorities on an individual basis. In case of shortfalls in admission capacities, the requirement of acute emergency care may necessitate that isolation and cohorting in the hospital will have to be performed temporarily in a less restrictive way than recommended here for standard.
- Published
- 2020
13. Antibiotische Standardtherapie häufiger Infektionskrankheiten in der ambulanten Pädiatrie
- Author
-
Johannes Hübner, H. Renk, Arne Simon, J. Pfeil, Reinhard Berner, W. Klein, Markus Hufnagel, S. Kummer, Johannes G. Liese, Stefan Trapp, S. Reinke, R. Tillmann, and T. Parlowsky
- Subjects
Gynecology ,03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,business.industry ,0502 economics and business ,05 social sciences ,Pediatrics, Perinatology and Child Health ,medicine ,050211 marketing ,Surgery ,030212 general & internal medicine ,business - Abstract
Zusammenfassung Hintergrund Die zunehmende Verbreitung von Antibiotikaresistenzen und die fehlende Weiterentwicklung von neuen Antibiotika erfordern eine rationale, leitlinienkonforme Antibiotikatherapie. Das gilt v. a. für die ambulante Medizin, in deren Bereich 85 % aller Antibiotika verordnet werden. Ziele Die Arbeitsgemeinschaft Antibiotic Stewardship ambulante Pädiatrie hat praxisnahe Empfehlungen zur antibiotischen Standardtherapie häufiger Infektionskrankheiten in der pädiatrischen Praxis formuliert. Material und Methoden Die Empfehlungen berücksichtigen Leitlinien zur rationalen Antibiotikatherapie und sind nach einem Konsentierungsprozess unter Beteiligung der Fachgesellschaften Berufsverband der Kinder- und Jugendärzte (BVKJ) und Deutsche Gesellschaft für pädiatrische Infektiologie (DGPI) erstellt worden. Ergebnisse Kurz gefasste Empfehlungen zur antibiotischen Standardbehandlung der häufigsten ambulant erworbenen Infektionskrankheiten der oberen und unteren Atemwege, Harnwege, Haut, Augen und Darm sowie in der Kinderchirurgie. Schlussfolgerung Mit den Empfehlungen soll sowohl eine Reduktion als auch eine Verbesserung der Qualität der Antibiotikaverordnungen in der ambulanten Pädiatrie erreicht werden. Unnötige Antibiotikatherapien sollen vermieden bzw. rasch beendet werden. Bei unklaren Situationen ohne Risikokonstellation soll statt einer antibiotischen Therapie eine kurzfristige Kontrolle vorgenommen werden. Antibiotika sollen so kurz und so schmal wie möglich verschrieben werden. Topische Antibiotika sollen vermieden werden, ebenso kritische Antibiotika wie Cephalosporine und Azithromycin (Risikofaktoren für eine Resistenzentwicklung). Es wird angeregt, die Empfehlungen in einem lokalen intersektoralen Konsensprozess anzupassen, um breite Akzeptanz und Verbindlichkeit zu steigern sowie Konflikte zu reduzieren, die sich aus der hohen Variabilität der Verordnungspraxis ergeben.
- Published
- 2020
14. Neonatal and young infant sepsis by Group B Streptococci and Escherichia coli: a single-center retrospective analysis in Germany—GBS screening implementation gaps and reduction in antibiotic resistance
- Author
-
Alexander Thürmer, Jennifer Lucia Winkler, Reinhard Berner, Barbara Seipolt, Jakob Peter Armann, Mario Rüdiger, Lars Mense, and Maren Doenhardt
- Subjects
Group B Streptococcus ,medicine.medical_specialty ,Antibiotic resistance ,medicine.drug_class ,Antibiotics ,Group B ,Streptococcus agalactiae ,Sepsis ,03 medical and health sciences ,0302 clinical medicine ,Pregnancy ,Germany ,Streptococcal Infections ,030225 pediatrics ,Internal medicine ,Epidemiology ,Escherichia coli ,Intrapartum antibiotic prophylaxis (IAP) ,Humans ,Medicine ,030212 general & internal medicine ,Pregnancy Complications, Infectious ,Antibiotic prophylaxis ,Retrospective Studies ,Neonatal sepsis ,business.industry ,Infant, Newborn ,Infant ,Drug Resistance, Microbial ,Antibiotic Prophylaxis ,medicine.disease ,Antimicrobial ,Anti-Bacterial Agents ,Pediatrics, Perinatology and Child Health ,Original Article ,Female ,Neonatal Sepsis ,business - Abstract
The last nationwide surveillance study on neonatal and young infant sepsis due to Group B Streptococci (GBS) and Escherichia coli in Germany was conducted between 2009 and 2010. The aim of this study is to provide longitudinal epidemiological data on neonatal and young infant sepsis caused by GBS and E. coli to reevaluate existing data and to inform clinical decision-making. Every positive blood culture for GBS and E. coli within the first 90 days of life that occurred at our center from 2008 until 2018 was identified. The epidemiological, clinical, laboratory, and microbiological data of all affected patients were analyzed through retrospective chart review, along with the pathogen’s antimicrobial susceptibility results. In total, 106 episodes of neonatal sepsis were described; 31% (n = 33) being caused by GBS and 69% (n = 73) by E. coli; 87% of GBS early-onset disease (EOD) cases did not receive intrapartum antibiotic prophylaxis (IAP). Contrary to general trends, the proportion of resistant E. coli isolates decreased for all tested antibiotics over time. Coincidentally, antenatal antibiotic use beyond IAP during that period decreased significantly in our center.Conclusions: (1) Data at our center suggests at least a regional implementation gap in GBS screening and IAP. (2) The decline in the resistance rate of E. coli for all antimicrobial substances might indicate that the reduction of prenatal antibiotics use is beneficial and that neonatal antibiotic stewardship programs should include pregnant women as well. What is Known:• GBS screening and intrapartum antibiotic prophylaxis led to a 32%-reduction in GBS disease in Germany with a 0.75 (92:122) ratio of early-onset disease to late-onset disease in 2009–2010.• Prenatal antibiotic use might increase the risk of E. coli early-onset disease and antibiotic resistances. What is New:• The GBS early-onset disease rates were twice as high as those of late-onset disease, the ratio was 1.75 (21:12) in 2008–2018 at our institution. This suggests that there are at least regional implementation gaps in the antenatal GBS screening in Germany.• We found a decline in E. coli resistance rates over time for all antimicrobial substances. Reduction in use of prenatal antibiotics might be an explanation.
- Published
- 2020
15. COVID-19 bei hospitalisierten Kindern und Jugendlichen
- Author
-
Reinhard Berner, A. Streng, J Armann, K. Hartmann, and Johannes G. Liese
- Subjects
Gynecology ,03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,business.industry ,Pediatrics, Perinatology and Child Health ,medicine ,Surgery ,030212 general & internal medicine ,030204 cardiovascular system & hematology ,business - Abstract
Das klinische Wissen zu Verlauf, Komplikationen und Therapie von COVID-19 bei Kindern und Jugendlichen ist bisher begrenzt. Der vorliegende systematische Review fasst die aktuelle wissenschaftliche Evidenz zum klinischen Verlauf von COVID-19 bei hospitalisierten Kindern zusammen. Zusatzlich werden die ersten Daten aus Deutschland aus einem Kinderklinik-Survey der Deutschen Gesellschaft fur Padiatrische Infektiologie e. V. (DGPI) vorgestellt. Ausgewertet wurden insgesamt 12 Fallserien aus China mit 6 bis 2143 SARS-CoV-2-infizierten Kindern, die uber eine PubMed-Literatursuche bis zum 31.03.2020 identifiziert wurden. Die Datenbank des deutschlandweiten COVID-19 Kinderklinik-Survey der DGPI wurde am 06.04.2020 abgefragt. In den Fallserien lag das mediane Alter zwischen 2 und 7 Jahren, mit einem Anteil von Sauglingen von 18 bis 45 %. Am haufigsten berichtete Symptome waren Fieber und Husten; bei 40–100 % lag eine radiologisch (zumeist CT) bestatigte Lungenbeteiligung vor. Schwere/kritische Verlaufe – inklusive 2 Todesfalle – wurden bei bis zu 8 % der Kinder berichtet. Die Hospitalisierungsdauer lag bei 5 bis 20 Tagen. Der COVID-19-Survey der DGPI erfasste bis zum 06.04.2020 33 Kinder aus 21 Kliniken, mit uberwiegenden Infektionen der oberen Atemwege. 45 % waren Sauglinge, 32 % hatten eine Vorerkrankung. Bislang benotigten 3 Kinder (9 %) eine intensivstationare Behandlung. COVID-19 bei hospitalisierten Kindern und Jugendlichen verlauft uberwiegend als unkomplizierte febrile Erkrankung der oberen oder der unteren Atemwege. Nur sehr selten kommt es bei Kindern zu schweren Komplikationen oder Todesfallen. Weitere Informationen zum Verlauf von COVID-19 bei Neugeborenen, Sauglingen und Patienten mit Vorerkrankungen sowie zu therapeutischen und praventiven Masnahmen werden dringend benotigt.
- Published
- 2020
16. Survival of Group A Streptococcus (GAS) is Enhanced Under Desiccated Culture Conditions
- Author
-
Leonhard Menschner, Peter Konrad, Nicole Toepfner, Reinhard Berner, and Uta Falke
- Subjects
Adolescent ,Genotype ,Streptococcus pyogenes ,Population ,medicine.disease_cause ,Applied Microbiology and Biotechnology ,Microbiology ,Group A ,Article ,03 medical and health sciences ,Tonsillar crypts ,Streptococcal Infections ,medicine ,Humans ,Desiccation ,Child ,education ,Tonsillopharyngitis ,Survival rate ,030304 developmental biology ,Antigens, Bacterial ,0303 health sciences ,education.field_of_study ,Microbial Viability ,biology ,030306 microbiology ,Streptococcus ,Infant ,Correction ,Pharyngitis ,General Medicine ,biology.organism_classification ,medicine.anatomical_structure ,Child, Preschool ,Reinfection ,Carrier Proteins ,Bacteria ,Bacterial Outer Membrane Proteins - Abstract
Streptococcus pyogenes or Group A Streptococcus (GAS) infections are the leading cause of bacterial tonsillopharyngitis. The bacterium can survive and persist within the human host for a long time as it is observed in up to 40% of the population who are considered as carriers. Recurrent tonsillopharyngitis is a particular problem in children which is caused either by relapses due to failed bacterial clearance or by reinfection. A prolonged survival in tonsillar crypts or on inanimate surfaces might be sources for reinfection. We therefore examined 64 clinical GAS isolates from children with tonsillopharyngitis for their long-term survival under either liquid or desiccated culture conditions. After 6 weeks, the overall GAS survival rate was 400-fold increased under desiccated culture conditions compared to liquid culture conditions, but varied depending on the emm-type between 20-fold (emm4) and 14000-fold (emm3). The survival rates of isolates from emm75 were significantly lower which is probably due to their production of hydrogen peroxide up to fatal doses. No hydrogen peroxide production could be detected for other emm-types. Furthermore, 11 isolates from patients with recurrent tonsillopharyngitis were compared to isolates of the same emm-type from patients with single episodes of tonsillopharyngitis. A significant elevated pH value and an increased survival rate for isolates from patients with recurrent infections were observed. In conclusion, significant differences in long-term survival of different GAS isolates as well as survival under desiccated culture conditions might contribute to both failed bacterial clearance and reinfection in patients with recurrent tonsillopharyngitis.
- Published
- 2020
17. Advanced therapy medicinal products : Synopsis of the statement of the German Society of Pediatrics and Adolescent Medicine (DGKJ)
- Author
-
Ulrike Schara, Georg F. Hoffmann, Ingeborg Krägeloh-Mann, Egbert Herting, Reinhard Berner, Jutta Gärtner, Thomas Klingebiel, Fred Zepp, and Wolfgang Rascher
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,Pediatrics, Perinatology and Child Health ,Medizin ,Child and adolescent psychiatry ,Medicine ,Surgery ,business - Published
- 2020
18. Monatsschrift Kinderheilkunde dankt den Gutachtern 2021
- Author
-
Fred Zepp, Reinhard Berner, Gesine Hansen, and Reinhold Kerbl
- Subjects
Pediatrics, Perinatology and Child Health ,Surgery - Published
- 2022
19. Fieber ohne Fokus beim jungen Säugling
- Author
-
Reinhard Berner and D. Nadal
- Subjects
Gynecology ,03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,business.industry ,030225 pediatrics ,Pediatrics, Perinatology and Child Health ,medicine ,Surgery ,business ,030217 neurology & neurosurgery - Abstract
Fieber ist im Kindesalter in bis zu 20 % der Falle der Grund fur eine Arztkonsultation. Die Hauptsteuerung der Korpertemperatur erfolgt im Zentralnervensystem. Fieber ist meist eine Abwehrreaktion auf Infektionserreger. Bei jungen Sauglingen (Alter ≤ 3 Monate) wird Fieber als eine Rektaltemperatur >38,0 °C definiert. Die klinische Entitat Fieber ohne Fokus (FOF) wird einzig bei Sauglingen und Kleinkindern beobachtet. Sie stellt eine bedeutende Herausforderung dar: Die klinische Beurteilung fuhrt zur Entscheidung, ob die Wahrscheinlichkeit fur eine schwere bakterielle Infektion, sprich fur einen gefahrlichen Verlauf, als hoch oder gering anzunehmen ist, und bestimmt somit das therapeutische Vorgehen. Standardisierte klinische Voraussagemodelle fur FOF sind ohne zusatzliche Diagnostik fur die klinische Praxis von begrenztem Wert. Erganzend zur klinischen Einschatzung verbessert die durchdachte Bestimmung von Laborparametern die Wahrscheinlichkeitsabschatzung und das therapeutische Vorgehen entscheidend.
- Published
- 2019
20. Hydrogen Peroxide Production of Group A Streptococci (GAS) is emm-Type Dependent and Increased at Low Temperatures
- Author
-
Uta Falke, Reinhard Berner, Leonhard Menschner, Nicole Toepfner, and Peter Konrad
- Subjects
Streptococcus pyogenes ,Catabolite repression ,Bacillus subtilis ,Biology ,Applied Microbiology and Biotechnology ,Microbiology ,Mixed Function Oxygenases ,03 medical and health sciences ,chemistry.chemical_compound ,Bacterial Proteins ,Streptococcal Infections ,Consensus sequence ,Humans ,Hydrogen peroxide ,Incubation ,Gene ,030304 developmental biology ,chemistry.chemical_classification ,Antigens, Bacterial ,0303 health sciences ,030306 microbiology ,Temperature ,Gene Expression Regulation, Bacterial ,Hydrogen Peroxide ,General Medicine ,Oxidants ,biology.organism_classification ,Repressor Proteins ,Enzyme ,Biochemistry ,chemistry ,CCPA ,Carrier Proteins ,Energy Metabolism ,Bacterial Outer Membrane Proteins - Abstract
Group A streptococcus (GAS) is an important human pathogen whose clinical isolates differ in their ability to produce hydrogen peroxide (H2O2). H2O2 is primarily produced by the enzyme lactate oxidase (LctO), an in depth in silico research revealed that all genome-sequenced GAS possess the required gene lctO. The importance of lctO for GAS is underlined by its highly conserved catabolite control element (cre box) as well as its perfect promotor sequence in comparison to the known consensus sequences of the Gram-positive model organism Bacillus subtilis. In this study, we provide further insight in the function and regulation of lactate oxidase by analyzing a large group of clinical GAS isolates. We found that H2O2 production increased over time in the late stationary phase; after 4 days of incubation, 5.4% of the isolates showed a positive result at 37 °C, while the rate increased to 16.4% at 20 °C. This correlation between H2O2 production and low temperatures suggests additional regulatory mechanisms for lctO besides catabolite control protein A (CcpA) and indicates that lctO might play a role for GAS energy metabolism at sub-body temperatures. Furthermore, we could identify that H2O2 production was different among clinical isolates; we could correlate H2O2 production to emm-types, indicating that emm-types 6 and 75 had the highest rate of H2O2 production. The emm-type- and temperature-dependent H2O2 production of clinical GAS isolates might contribute to their different survival strategies.
- Published
- 2019
21. Mit dieser Erhebung sind die Beeinträchtigungen durch das Masketragen bei Kindern nicht objektivierbar
- Author
-
Reinhard Berner, I. Eckhardt, B. Rodeck, Ingeborg Krägeloh-Mann, Johannes Hübner, Corona-Taskforce der Deutschen Gesellschaft für Kinder und Jugendmedizin, D. T. Schneider, and Ulrich Heininger
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,Pediatrics, Perinatology and Child Health ,Pediatric surgery ,medicine ,Child and adolescent psychiatry ,Surgery ,business - Published
- 2021
22. Dilemma der Bewertung Hans Aspergers und der Interpretation historischer Quellen
- Author
-
die Federführende Schriftleitung Monatsschrift Kinderheilkunde, Reinhold Kerbl, Reinhard Berner, Fred Zepp, and Gesine Hansen
- Subjects
medicine.medical_specialty ,business.industry ,Pediatrics, Perinatology and Child Health ,Pediatric surgery ,Child and adolescent psychiatry ,medicine ,Surgery ,business ,Psychiatry - Published
- 2021
23. Erratum zu: Antibiotische Standardtherapie häufiger Infektionskrankheiten in der ambulanten Pädiatrie
- Author
-
Reinhard Berner, Johannes Hübner, H. Renk, S. Kummer, W. Klein, J. Pfeil, S. Reinke, Markus Hufnagel, Stefan Trapp, Johannes G. Liese, R. Tillmann, T. Parlowsky, and Arne Simon
- Subjects
Pediatrics ,medicine.medical_specialty ,business.industry ,Pediatrics, Perinatology and Child Health ,Pediatric surgery ,Child and adolescent psychiatry ,Medicine ,Surgery ,business - Published
- 2021
24. Prevalence and molecular diversity of invasive Streptococcus dysgalactiae and Streptococcus pyogenes in a German tertiary care medical centre
- Author
-
Nicole Toepfner, S Rößler, Reinhard Berner, and E Jacobs
- Subjects
0301 basic medicine ,Microbiology (medical) ,medicine.medical_specialty ,Streptococcus pyogenes ,030106 microbiology ,medicine.disease_cause ,Streptococcus agalactiae ,Microbiology ,Tertiary Care Centers ,03 medical and health sciences ,Medical microbiology ,Germany ,Streptococcal Infections ,Streptococcus pneumoniae ,Prevalence ,Humans ,Medicine ,Blood culture ,Typing ,Antigens, Bacterial ,Molecular Epidemiology ,Molecular epidemiology ,biology ,medicine.diagnostic_test ,business.industry ,General Medicine ,biology.organism_classification ,Infectious Diseases ,Blood Culture ,business ,Streptococcus dysgalactiae ,Bacterial Outer Membrane Proteins - Abstract
Prevalence of invasive ß-haemolytic streptococci (BHS) at a tertiary care hospital and molecular diversity of S. pyogenes and S. dysgalactiae was studied. Between 2012 and 2016, all blood culture sets (n = 55,839), CSF (n = 8413) and soft tissue (n = 20,926) samples were analysed for BHS positivity using HYBASE software. Molecular profiles of 99 S. pyogenes and S. dysgalactiae were identified by sequencing of M protein genes (emm types) and multiplex PCR typing of 20 other virulence determinants. Streptococci contributed to 6.2% of blood, 10.7% of CSF and 14.5% of soft tissue isolates, being among the most common invasive isolates. The overall rates of invasive S. pyogenes, S. agalactiae, S. dysgalactiae and S. pneumoniae were 2.4, 4.4, 2.1, and 5.3%. Whereas S. pneumoniae was 1.5% more common in CSF samples, BHS isolates were 2-fold and 11-fold higher in bacteraemia and invasive soft tissue infections. Genetic BHS typing revealed wide molecular diversity of invasive and noninvasive group A and group G BHS, whereas one emm-type (stG62647.0) and no other virulence determinants except scpA were detected in invasive group C BHS. BHS were important invasive pathogens, outpacing S. pneumoniae in bacteraemia and invasive soft tissue infections. The incidence of S. dysgalactiae infections was comparable to that of S. pyogenes even with less diversity of molecular virulence. The results of this study emphasise the need for awareness of BHS invasiveness in humans and the need to develop BHS prevention strategies.
- Published
- 2018
25. Pyogene Haut- und Weichgewebeinfektionen
- Author
-
Reinhard Berner and N. Töpfner
- Subjects
Gynecology ,03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,business.industry ,030225 pediatrics ,Pediatrics, Perinatology and Child Health ,medicine ,Surgery ,030212 general & internal medicine ,business - Abstract
Haut- und Weichgewebeinfektionen zahlen zu den haufigsten bakteriellen Infektionen im Kindes- und Jugendalter. Neben der initial meist klinisch-deskriptiven Diagnose ist die differenzierte Betrachtung der Erreger notwendig, um eine empirische antibiotische Therapie kalkuliert einsetzen und diese – nach entsprechender Diagnostik und Verlaufsbeurteilung – gezielt anpassen zu konnen. Uberwiegend verursachen im Kindesalter Staphylococcus aureus und β‑hamolysierende Streptokokken der Lancefield-Gruppen A (S. pyogenes), C und G Haut- und Weichgewebeinfektionen. (Misch‑)Infektionen durch gramnegative Bakterien und Anaerobier sind v. a. unter Immunsuppression, bei verschmutzten Wunden, bei Abszedierungen aus dem Intestinal- oder Genitaltrakt sowie nach Bissverletzungen zu berucksichtigen. Die differenzialdiagnostische Abgrenzung zu autoinflammatorisch- und autoimmunvermittelten Systemerkrankungen kann im Einzelfall schwierig sein. Das fruhzeitige Erkennen insbesondere von nekrotisierender Fasziitis, Toxinschocksyndrom und Gasbrand/-gangran ist von entscheidender prognostischer Bedeutung. Aufgrund potenziell hoher Letalitat erfordern diese Infektionen neben kalkulierter antibiotischer und adjuvanter Therapie umgehende intensivmedizinische und ggf. chirurgische Masnahmen.
- Published
- 2017
26. Erratum zu: Arzneimittel für neuartige Therapien – Perspektiven, Chancen, Herausforderungen
- Author
-
Reinhard Berner, Georg F. Hoffmann, Ulrike Schara, Egbert Herting, Jutta Gärtner, Fred Zepp, Thomas Klingebiel, Ingeborg Krägeloh-Mann, and Wolfgang Rascher
- Subjects
medicine.medical_specialty ,business.industry ,Family medicine ,Pediatrics, Perinatology and Child Health ,Pediatric surgery ,Child and adolescent psychiatry ,medicine ,Surgery ,business - Published
- 2021
27. Correction to: Survival of Group A Streptococcus (GAS) is Enhanced Under Desiccated Culture Conditions
- Author
-
Nicole Toepfner, Peter Konrad, Leonhard Menschner, Uta Falke, and Reinhard Berner
- Subjects
Credit line ,Third party ,Statutory law ,Law ,Reproduction (economics) ,Internet portal ,General Medicine ,Creative commons ,Biology ,Applied Microbiology and Biotechnology ,Microbiology ,License - Abstract
The article “Survival of Group A Streptococcus (GAS) is Enhanced Under Desiccated Culture Conditions”, written by Leonhard Menschner, Uta Falke, Peter Konrad, Nicole Toepfner, Reinhard Berner, was originally published electronically on the publisher's internet portal on 2 April 2020 without open access. With the author(s)' decision to opt for Open Choice the copyright of the article changed on 4 June 2021 to © The Author(s) 2020 and the article is forthwith distributed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0.
- Published
- 2021
28. Genetische Methoden für die Analyse autoinflammatorischer Erkrankungen
- Author
-
Reinhard Berner, Stefanie Kretschmer, Angela Rösen-Wolff, Min Ae Lee-Kirsch, Marc Bienias, Victoria Tüngler, Christine Wolf, and N. König
- Subjects
0301 basic medicine ,Gynecology ,03 medical and health sciences ,medicine.medical_specialty ,030104 developmental biology ,0302 clinical medicine ,Rheumatology ,business.industry ,medicine ,030212 general & internal medicine ,business - Abstract
Das phanotypische und genetische Spektrum autoinflammatorischer Erkrankungen hat in den letzten Jahren stetig zugenommen. So sind mittlerweile mehrere monogen bedingte autoinflammatorische Erkrankungen bekannt, bei denen Fieberschube nicht im Vordergrund stehen und die neben Zeichen systemischer Entzundung auch Autoimmunphanomene oder eine pathologische Infektanfalligkeit aufweisen. Fur autoinflammatorische Erkrankungen, die mit einer unkontrollierten Aktivitat der Zytokine, IL-1β, TNF-α oder Typ-1-IFN einhergehen, stehen kausale Therapien zur Verfugung. Daher kommt der Sicherung der genetischen Diagnose eine grose Rolle zu. Die molekulargenetische Abklarung eines Patienten mit Autoinflammation sollte in Abhangigkeit von der Symptomkonstellation stufenweise erfolgen. Bei eindeutigen Symptomen kann als Erstes die Einzelgensequenzierung erfolgen. NGS-basierte Methoden wie die Panelsequenzierung und die Exomsequenzierung sowie die Array-CGH sind bei unklarer Symptomatik sinnvoll.
- Published
- 2017
29. The 'Choosing Wisely' initiative in infectious diseases
- Author
-
Clara Lehmann, Reinhard Berner, Johannes R. Bogner, Oliver A. Cornely, Katja de With, Susanne Herold, Winfried V. Kern, Sebastian Lemmen, Mathias W. Pletz, Bernhard Ruf, Bernd Salzberger, Hans Jürgen Stellbrink, Norbert Suttorp, Andrew J. Ullmann, Gerd Fätkenheuer, and Norma Jung
- Subjects
Microbiology (medical) ,medicine.medical_specialty ,Alternative medicine ,Health Promotion ,Unnecessary Procedures ,030204 cardiovascular system & hematology ,Global Health ,Communicable Diseases ,03 medical and health sciences ,0302 clinical medicine ,Germany ,Unnecessary Procedure ,medicine ,Global health ,Humans ,030212 general & internal medicine ,Asymptomatic bacteriuria ,Respiratory tract infections ,business.industry ,General Medicine ,Vaccination ,Infectious Diseases ,Health promotion ,Family medicine ,Public Health ,business ,Delivery of Health Care - Abstract
"Choosing Wisely" is a growing international campaign aiming at practice changes to improve patient health and safety by both, conduct of essential and avoidance of unnecessary diagnostic, preventive and therapeutic procedures. The goal is to create an easily recognizable and distributable list ("Choosing Wisely items") that addresses common over- and underuse in the management of infectious diseases.The German Society of Infectious Diseases (DGI) participates in the campaign "Klug Entscheiden" by the German Society of Internal Medicine. Committee members of the (DGI) listed potential 'Choosing Wisely items'. Topics were subjected to systematic evidence review and top ten items were selected for appropriateness. Five positive and negative recommendations were approved via individual member vote.The final recommendations are: (1) Imperatively start antimicrobial treatment and remove the focus in Staphylococcus aureus bloodstream infection. (2) Critically ill patients with signs of infection need early appropriate antibiotic therapy. (3) Annual influenza vaccination should be given to individuals with age60 years, patients with specific co-morbidities and to contact persons who may spread influenza to others. (4) All children should receive measles vaccine. (5) Prefer oral formulations of highly bioavailable antimicrobials whenever possible. (6) Avoid prescribing antibiotics for uncomplicated upper respiratory tract infections. (7) Do not treat asymptomatic bacteriuria with antibiotics. (8) Do not treat Candida detected in respiratory or gastrointestinal tract specimens. (9) Do not prolong prophylactic administration of antibiotics in patients after they have left the operating room. (10) Do not treat an elevated C-reactive protein (CRP) or procalcitonin with antibiotics for patients without signs of infection.Physicians will reduce potential harm to patients and increase the value of health care when implementing these recommendations.
- Published
- 2017
30. Diagnose und Therapie von Atemwegsinfektionen (ohne ambulant erworbene Pneumonie) bei ambulant behandelten Kindern ohne schwerwiegende Grunderkrankung
- Author
-
Reinhard Berner, Markus Hufnagel, Johannes G. Liese, Christoph Berger, Arne Simon, Hans-Iko Huppertz, M. Prelog, Stefan Trapp, Thomas Nicolai, Markus A. Rose, D. Nadal, Johannes Hübner, Johannes Forster, Tobias Tenenbaum, and Markus Knuf
- Subjects
Gynecology ,03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,business.industry ,030225 pediatrics ,Pediatrics, Perinatology and Child Health ,medicine ,Surgery ,030212 general & internal medicine ,business - Abstract
Atemwegsinfektionen (AWI) sind die haufigste Indikation fur eine Antibiotikatherapie bei Kindern und Jugendlichen, v. a. im ambulanten Bereich und im kinderarztlichen Notdienst der Kliniken. Die hier vorliegende Konsensusempfehlung verschiedener padiatrischer Fachgesellschaften und des Berufsverbandes der niedergelassenen Kinder‐ und Jugendarzte beschreibt in Kurze die klinischen Symptome und die Diagnostik sowie die Indikationen fur eine leitlinienkonforme antibiotische Therapie von AWI (exklusive Pneumonie). Sie soll Kinder- und Jugendmediziner bei einem restriktiven Antibiotikaeinsatz, bei der Auswahl des bestmoglichen Antibiotikums und im Hinblick auf eine moglichst kurze Therapiedauer unterstutzen. Des Weiteren werden AWI beschrieben, bei denen keine Antibiotikatherapie erfolgen sollte oder bei denen nur sehr selten eine Antibiotikatherapie erforderlich ist.
- Published
- 2017
31. Zentren für seltene Erkrankungen
- Author
-
TRANSLATE-NAMSE-Konsortium, Peter Burgard, Georg F. Hoffmann, A. Grüters-Kieslich, and Reinhard Berner
- Subjects
Gynecology ,03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,business.industry ,030225 pediatrics ,Pediatrics, Perinatology and Child Health ,medicine ,Surgery ,business ,030217 neurology & neurosurgery - Abstract
Der vom Nationalen Aktionsbundnis fur Menschen mit Seltenen Erkrankungen (NAMSE) ausgearbeitete nationale Aktionsplan sieht als eine zentrale Masnahme die Einrichtung von Zentren fur seltene Erkrankungen vor. Mithilfe einer Forderung des Innovationsfonds werden von April 2017 bis Marz 2020 neun universitare padiatrische Zentren fur seltene Erkrankungen diese Masnahme umsetzen und ihre Wirksamkeit evaluieren. In Kompetenzbereichen, krankheitsubergreifend (NAMSE-Typ-A-Zentren) und krankheitsspezifisch (NAMSE-Typ B-Zentren), werden sektorenubergreifende, IT-gestutzte Patientenpfade implementiert. Die Zentren fur seltene Erkrankungen bilden ein Netzwerk, das durch spezifische Expertenpanels die Qualitat der interdisziplinaren Diagnostik und Behandlung bei seltenen Erkrankungen uberregional verbessern soll. Die Beteiligung von Experten in standortubergreifenden Fallkonferenzen wird – fur den Patienten erkennbar – sicherstellen, dass die derzeit verfugbare Expertise fur das unklare oder seltene Krankheitsbild eingeholt wird. Die innovative genetische Diagnostik wird durch die Indikationsstellung im Expertenpanel und die Validierung mit Einbeziehung der behandelnden Arzte qualitatsgesichert durchgefuhrt. In der Versorgung von Patienten mit ausgewahlten Indikatordiagnosen, z. B. Krankheiten, die im Neugeborenenscreening detektiert werden, werden interdisziplinares Fallmanagement, Fallkonferenzen, Zugang zu einer prazisen Diagnostik und Therapie eine bessere Behandlungsqualitat erzielen. Die strukturierte Transition von der Padiatrie in die Erwachsenenmedizin wird die Nachhaltigkeit steigern. Eine verbesserte Kommunikation mit den Primarversorgern wird durch die IT-gestutzte Zugriffsmoglichkeit auf die aktualisierten Krankenhausdaten der Patienten erreicht, sodass Verzogerungen von notwendigen Masnahmen, z. B. von Therapieanpassungen, verhindert werden.
- Published
- 2017
32. Mythen in der pädiatrischen Infektiologie
- Author
-
Reinhard Berner
- Subjects
03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,business.industry ,030225 pediatrics ,Family medicine ,Pediatrics, Perinatology and Child Health ,Pediatric surgery ,medicine ,Child and adolescent psychiatry ,Surgery ,030212 general & internal medicine ,business - Published
- 2018
33. Erratum zu: Fieber ohne Fokus beim jungen Säugling
- Author
-
Reinhard Berner and D. Nadal
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,Pediatrics, Perinatology and Child Health ,Child and adolescent psychiatry ,Medicine ,Surgery ,business - Abstract
Erratum zu: Monatsschr Kinderheilkd 2019 https://doi.org/10.1007/s00112-019-00767-0 In Tabelle 5 (Diagnostisches Vorgehen bei jungen Sauglingen imAlter ≤90 Tage mit Fieber ohne Fokus (FOF), S. 937) hat sich ein Fehler eingeschlichen. Dort ist unter „Korperliche Untersuchung“ bei „Vitalzeichen“ der …
- Published
- 2019
34. Systemische juvenile idiopathische Arthritis
- Author
-
A. S. Kubasch, D. Föll, Reinhard Berner, and C. Hinze
- Subjects
030203 arthritis & rheumatology ,03 medical and health sciences ,medicine.medical_specialty ,Pediatrics ,0302 clinical medicine ,business.industry ,030225 pediatrics ,Pediatrics, Perinatology and Child Health ,Pediatric surgery ,Child and adolescent psychiatry ,medicine ,Surgery ,business - Published
- 2018
35. Unexpectedly high incidences of chronic non-bacterial as compared to bacterial osteomyelitis in children
- Author
-
Christian M. Hedrich, Ursula Range, Gabriele Hahn, Reinhard Berner, T. Siepmann, and Anja Schnabel
- Subjects
Male ,medicine.medical_specialty ,Pediatrics ,Hyperostosis ,Adolescent ,Immunology ,Arthritis ,Inflammatory bowel disease ,03 medical and health sciences ,0302 clinical medicine ,Rheumatology ,030225 pediatrics ,Internal medicine ,Pediatric surgery ,Humans ,Immunology and Allergy ,Medicine ,Child ,Prospective cohort study ,Retrospective Studies ,030203 arthritis & rheumatology ,business.industry ,Incidence ,Osteomyelitis ,Infant, Newborn ,Infant ,Bacterial Infections ,medicine.disease ,Child, Preschool ,Chronic Disease ,Oral and maxillofacial surgery ,Female ,business - Abstract
Historically, osteomyelitis was considered an infectious disorder. More recently, inflammatory mechanisms were recognized causing a significant proportion of pediatric osteomyelitis. This study was to compare characteristics of children with chronic non-bacterial (CNO) and bacterial osteomyelitis (BOM). A chart review of osteomyelitis patients from the departments of pediatrics, pediatric surgery, orthopedic surgery, and oral and maxillofacial surgery was conducted in a tertiary referral center, covering the years 2004–2014. Institutional incidences of CNO (n = 49) and BOM (n = 56) were comparable. Differentiation between CNO and BOM based on clinical or laboratory findings was mostly impossible. However, children with BOM more frequently presented with local inflammatory signs (47 vs. 68 %, p = 0.040), fever (12 vs. 38 %, p = 0.003), and abscesses (0 vs. 39 %, p < 0.001). Peripheral arthritis (14 vs. 0 %, p < 0.001), inflammatory bowel disease (10 vs. 2 %, p = ns), and hyperostosis (29 vs. 4 %, p = 0.001) were more common in CNO. Whole-body MRI was performed in 76 % of CNO patients, unveiling multifocal lesions in 80 % (CRMO). Though considered a rare disorder, institutional incidences of CNO were comparable to BOM, and the discrimination between CNO and BOM solely based on clinical aspects was mostly impossible. This is of special interest, since a correct and timely diagnosis is of utmost importance for long-term outcomes in both disorders. Whole-body MRIs should be considered in chronic osteomyelitis to (1) detect clinically inapparent lesions in CNO and (2) indirectly exclude (usually unifocal) chronic bacterial infections. Prospective studies are warranted to establish evidence-based diagnostic and therapeutic approaches to CNO.
- Published
- 2016
36. Chronische nichtbakterielle und bakterielle Osteomyelitis
- Author
-
Reinhard Berner, Anja Schnabel, and Christian M. Hedrich
- Subjects
030203 arthritis & rheumatology ,Gynecology ,03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,business.industry ,030225 pediatrics ,Pediatrics, Perinatology and Child Health ,Medicine ,Surgery ,business - Abstract
Entzundungen der knochernen Strukturen konnen im Kindes- und Jugendalter zur erheblichen Einschrankung der Lebensqualitat sowie zu psychischen und korperlichen Schaden fuhren. Entgegen der Annahme ausschlieslich infektioser Ursachen der Osteomyelitiden (OM) gewinnen zunehmend die nichtinfektiosen, (auto-)inflammatorischen Ursachen an Bedeutung. Die haufigste autoinflammatorische Knochenerkrankung ist die chronische nichtbakterielle Osteomyelitis (CNO), die vorwiegend das knocherne Skelett betrifft, aber auch inflammatorische Veranderungen an Haut, Darm und Gelenken verursachen kann. Das breite klinische Spektrum reicht von zeitlich limitierten Knochenentzundungen an einzelnen Knochen bis zu chronisch aktiven oder rekurrierenden Verlaufen mit symmetrischem Befall mehrerer Knochen. Der Beitrag fasst Daten bezuglich der Differenzialdiagnose infektioser und nichtinfektioser OM zusammen und gibt evidenzbasierte Empfehlungen zu Differenzialdiagnostik und Therapie der CNO.
- Published
- 2016
37. Therapie der rezidivierenden akuten Tonsillitis
- Author
-
Nicole Toepfner, Reinhard Berner, and J. Windfuhr
- Subjects
Gynecology ,03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,business.industry ,Pediatrics, Perinatology and Child Health ,Tonsillitis ,Medicine ,Surgery ,030212 general & internal medicine ,030223 otorhinolaryngology ,business ,medicine.disease - Abstract
Bei einer bundesweiten Erhebung regionaler Tonsillektomiehaufigkeiten wurden 2007–2012 deutliche Differenzen festgestellt, die auf eine unterschiedliche Gesundheitsversorgung innerhalb Deutschlands hinweisen. Als konsentierte Entscheidungsgrundlage wurde die S2k-Leitlinie der AWMF – Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF-Register Nr. 017/024) „Therapie entzundlicher Erkrankungen der Gaumenmandeln – Tonsillitis“ durch mehrere Fachgesellschaften entwickelt. Aufgrund der erhohten Morbiditat nach Tonsillektomie wird eine strenge, leitlinienkonforme Indikationsstellung empfohlen. Zur Entscheidung fur oder gegen eine operative Therapie der Gaumenmandeln muss bei jeder Episode des Krankheitsbildes „Halsschmerzen“ zwischen viraler und bakterieller Infektion unterschieden werden. Auserdem ist die Festlegung auf eine der folgenden Diagnosen zentral: „akute Tonsillitis“, „akute Tonsillopharyngitis“ oder „akute Pharyngitis“. Das therapeutische Vorgehen richtet sich entsprechend den Leitlinienempfehlungen nach der Zahl bakterieller Tonsillitiden und bakterieller Tonsillopharyngitiden uber einen arztlich evaluierten Beobachtungszeitraum von mindestens 12 Monaten.
- Published
- 2016
38. Klinische Symptome und Pathogenese der Typ-1-Interferonopathien
- Author
-
Reinhard Berner, M. Diesterheft, Victoria Tüngler, Min Ae Lee-Kirsch, Max Schuster, and Angela Rösen-Wolff
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,Pediatrics, Perinatology and Child Health ,Medicine ,Surgery ,business - Abstract
Die Typ-1-Interferonopathien stellen eine Gruppe genetisch bedingter seltener Erkrankungen dar, die durch eine Fehlfunktion des angeborenen Immunsystems hervorgerufen werden. Gemeinsames Kennzeichen ist eine Dysregulation der antiviralen Typ-1-Interferon(IFN)-Achse, die zu einer konstitutiven Typ-1-IFN-Aktivierung fuhrt. Als systemisch-entzundliche Erkrankungen ist das klinische Spektrum der Typ-1-Interferonopathien sehr breit und sowohl durch Autoinflammation als auch durch Autoimmunitat gekennzeichnet. Hierbei stehen neurologische und kutane Manifestationen im Vordergrund. Pathogenetisch liegen den Typ-1-Interferonopathien Storungen im Metabolismus und in der immunologischen Erkennung von intrazellularen Nukleinsauren zugrunde. Unser derzeitiges Verstandnis der molekularen Pathogenese der Typ-1-Interferonopathien weist darauf hin, dass eine immunmodulatorische Intervention, die der inadaquaten Typ-1-IFN-Aktvierung entgegenwirkt, therapeutisch wirksam sein konnte.
- Published
- 2015
39. Therapeutic Approaches to Type I Interferonopathies
- Author
-
Reinhard Berner, Stefanie Kretschmer, Marc Bienias, Min Ae Lee-Kirsch, Victoria Tüngler, Barbara Kind, Constanze Griep, Christine Wolf, and Normi Bruck
- Subjects
0301 basic medicine ,Autoimmunity ,medicine.disease_cause ,Autoimmune Diseases ,03 medical and health sciences ,0302 clinical medicine ,Immune system ,Rheumatology ,Interferon ,Humans ,Medicine ,Immunodeficiency ,Innate immune system ,business.industry ,medicine.disease ,Reverse transcriptase ,030104 developmental biology ,Interferon Type I ,Immunology ,Nucleic acid ,business ,Janus kinase ,Immunosuppressive Agents ,030217 neurology & neurosurgery ,medicine.drug - Abstract
To review recent scientific advances and therapeutic approaches in the expanding field of type I interferonopathies. Type I interferonopathies represent a genetically and phenotypically heterogenous group of disorders of the innate immune system caused by constitutive activation of antiviral type I interferon (IFN). Clinically, type I interferonopathies are characterized by autoinflammation and varying degrees of autoimmunity or immunodeficiency. The elucidation of the underlying genetic causes has revealed novel cell-intrinsic mechanisms that protect the organism against inappropriate immune recognition of self nucleic acids by cytosolic nucleic acid sensors. The type I IFN system is subject to a tight and complex regulation. Disturbances of its checks and balances can spark an unwanted immune response causing uncontrolled type I IFN signaling. Novel mechanistic insight into pathways that control the type I IFN system is providing opportunities for targeted therapeutic approaches by repurposing drugs such as Janus kinase inhibitors or reverse transcriptase inhibitors.
- Published
- 2018
40. Sind Aminoglykoside noch zeitgemäß?
- Author
-
Reinhard Berner and Johannes Hübner
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,Medicine ,business - Abstract
Der Einsatz von Aminoglykosiden, wie Genatamicin und Amikacin, in der Therapie bakterieller Infektionen ist heute umstritten. Doch angesichts zunehmender Antibiotikaresistenzen stellt sich die Frage: Kommt die Padiatrie tatsachlich ohne Aminoglykoside aus oder haben diese Antibiotika nach wie vor ihren Stellenwert?
- Published
- 2018
41. β-hemolytic streptococcal throat carriage and tonsillopharyngitis: a cross-sectional prevalence study in Gabon, Central Africa
- Author
-
Reinhard Berner, Nicole Toepfner, Benjamin Arnold, Sabine Bélard, and Abraham Alabi
- Subjects
Adult ,Male ,Microbiology (medical) ,medicine.medical_specialty ,Adolescent ,Streptococcus pyogenes ,Cross-sectional study ,Biology ,medicine.disease_cause ,Group A ,Young Adult ,Risk Factors ,Streptococcal Infections ,Internal medicine ,Throat ,Epidemiology ,Odds Ratio ,Prevalence ,medicine ,Animals ,Humans ,Gabon ,Child ,Tonsillopharyngitis ,Aged ,Aged, 80 and over ,Streptococcus ,Infant ,Pharyngitis ,General Medicine ,Middle Aged ,Cross-Sectional Studies ,Infectious Diseases ,medicine.anatomical_structure ,Carriage ,Child, Preschool ,Carrier State ,Immunology ,Pharynx ,Female - Abstract
Group A streptococcus (GAS) and possibly other β-hemolytic streptococci (BHS) account for a considerable morbidity and mortality burden in African populations; however, disproportionately little is known about the epidemiology of BHS in sub-Saharan Africa. This study assessed the prevalence of GAS, group G streptococcus (GGS) and group C streptococcus (GCS) carriage and tonsillopharyngitis in a Central African population.A prospective cross-sectional study was performed to assess the prevalence of and risk factors for BHS carrier status and tonsillopharyngitis in children and adults in Gabon.The overall BHS carrier prevalence was 135/1,005 (13.4%); carrier prevalence of GAS, GGS, and GCS was 58/1,005 (5.8%), 50/1,005 (5.0%), and 32/1,005 (3.2%), respectively. Streptococcal carriage was associated with school and pre-school age (adjusted OR 2.65, 95% CI 1.62-4.36, p = 0.0001 and 1.90, 95% CI 1.14-3.17, p = 0.0141, respectively). Participants residing in urban areas were less likely carriers (OR 0.52, p = 0.0001). The point-prevalence of BHS-positive tonsillopharyngitis was 1.0% (9/1,014) and 15.0% (6/40) in school children with sore throat.Non-GAS exceeded GAS throat carriage and tonsillopharyngitis suggesting a yet underestimated role of non-GAS streptococci in BHS diseases.
- Published
- 2014
42. Abstracts of the 52nd Workshop for Pediatric Research
- Author
-
Rhea van den Bruck, Patrick P. Weil, Thomas Ziegenhals, Philipp Schreiner, Stefan Juranek, Daniel Gödde, Silvia Vogel, Frauke Schuster, Valerie Orth, Johannes Dörner, Daniel Pembaur, Meike Röper, Stefan Störkel, Hubert Zirngibl, Stefan Wirth, Andreas C. W. Jenke, Jan Postberg, Nikolas Boy, Jana Heringer, Gisela Haege, Esther M. Glahn, Georg F. Hoffmann, Sven F. Garbade, Peter Burgard, Stefan Kölker, Cho-Ming Chao, Faady Yahya, Alena Moiseenko, Amit Shrestha, Negah Ahmadvand, Jennifer Quantius, Jochen Wilhelm, Elie El-Agha, Klaus-Peter Zimmer, Saverio Bellusci, Christian Staufner, Holger Prokisch, Stephan Seeliger, Matthias Müller, Andreas Hippe, Henrik Steinkraus, Roland Wauer, Burkhard Lachmann, Sigrun R. Hofmann, Christian M. Hedrich, Jakob Zierk, Farhad Arzideh, Rainer Haeckel, Wolfgang Rascher, Manfred Rauh, Markus Metzler, Sebastian Thieme, Joanna Bandoła, Cornelia Richter, Martin Ryser, Arshad Jamal, Michelle P. Ashton, Malte von Bonin, Matthias Kuhn, Ezio Bonifacio, Reinhard Berner, Sebastian Brenner, Johanna Hammersen, Cristina Has, Nora Naumann-Bartsch, Daniel Stachel, Dimitra Kiritsi, Stephan Söder, Mathilde Tardieu, Leena Bruckner-Tuderman, Holm Schneider, F. Bohne, D. Langer, R. Cencic, T. Eggermann, U. Zechner, J. Pelletier, F. Zepp, T. Enklaar, D. Prawitt, Martin Pech, Markus Weckmann, Femke-Anouska Heinsen, Andre Franke, Christine Happle, Anna-Maria Dittrich, Gesine Hansen, Oliver Fuchs, Erika von Mutius, Brian G. Oliver, Matthias V. Kopp, Claudia Paret, Alexandra Russo, Johanna Theruvath, Bettina Keller, Khalifa El Malki, Nadine Lehmann, Arthur Wingerter, Marie A. Neu, Gerhold-Ay Aslihan, Wolfgang Wagner, Clemens Sommer, Torsten Pietsch, Larissa Seidmann, Jörg Faber, Felix Schreiner, Merle Ackermann, Michael Michalik, Eva Rother, Andras Bilkei-Gorzo, Ildiko Racz, Laura Bindila, Beat Lutz, Jörg Dötsch, Andreas Zimmer, Joachim Woelfle, Hendrik S. Fischer, Tim L. Ullrich, Christoph Bührer, Christoph Czernik, Gerd Schmalisch, Robert Stein, Judith Hagenbuchner, Ursula Kiechl-Kohlendorfer, Petra Obexer, Michael J. Ausserlechner, Niki T. Loges, Adrien Tobias Frommer, Julia Wallmeier, Heymut Omran, Soner Öner-Sieben, Martina Gimpfl, Jan Rozman, Martin Irmler, Johannes Beckers, Martin Hrabe De Angelis, Adelbert Roscher, Eckhard Wolf, Regina Ensenauer, Karolina Nemes, Michael Frühwald, Martin Hasselblatt, Reiner Siebert, Uwe Kordes, Marcel Kool, Haicui Wang, Holly Hardy, Osama Refai, Katy E. S. Barwick, Holly H. Zimmerman, Joachim Weis, Emma L. Baple, Andrew H. Crosby, Sebahattin Cirak, C. Hellmuth, O. Uhl, M. Standl, J. Heinrich, E. Thiering, B. Koletzko, Lena Blümel, Kornelius Kerl, Daniel Picard, Michael C. Frühwald, Max C. Liebau, Guido Reifenberger, Arndt Borkhardt, Marc Remke, D. Tews, M. Wabitsch, P. Fischer-Posovszky, Mike-Andrew Westhoff, Lisa Nonnenmacher, Julia Langhans, Lukas Schneele, Nancy Trenkler, and Klaus-Michael Debatin
- Subjects
0303 health sciences ,medicine.medical_specialty ,business.industry ,Pediatric research ,MEDLINE ,Pharmaceutical Science ,medicine.disease ,03 medical and health sciences ,0302 clinical medicine ,030228 respiratory system ,Complementary and alternative medicine ,Medicine ,Pharmacology (medical) ,business ,Intensive care medicine ,030304 developmental biology ,Primary ciliary dyskinesia - Published
- 2017
43. Proceedings of the 2016 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Scientific Meeting
- Author
-
Peggy Lee, Victor Hasselblad, Anja Schnabel, Timo Siepmann, Liza Bermudez, Ting Wang, Gloria C. Higgins, Ann M. Reed, Reinhard Berner, Katharine Moore, Sriharsha Grevich, Amy J. Starr, Jerome C. Lane, Mark F. Hoeltzel, Emily von Scheven, Yvonne Chiu, Brian M. Feldman, Edward J Oberle, Susan Kim, Laurence Greenbaum, Adam M. Huber, Judyann C. Olson, Suzanne Li, Lorie Luyrink, Elizabeth Roth Wojcicki, Dana Toib, Doruk Erkan, Michelle Bayer, Rie Karasawa, Lynn Spiegel, Charles Victor, Polly J. Ferguson, T. Brent Graham, Mark Connelly, James N. Jarvis, Laura B Lewandowski, Jacinthe Bisaillon, Elizabeth D. Mellins, Stephanie Luca, Gloria Higgins, Suhas Ganguli, Mary Hintermeyer, Jennifer E. Weiss, Jessica Foster, Phillip I. Tarr, Timothy S. H. Kwok, Kristyn L. Maletta, Christine Smith, Mileka Gilbert, Shirley M. L. Tse, L. Nandini Moorthy, Ciaran Duffy, Beatrice Goilav, Kevin Baszis, Rayfel Schneider, Marc D. Natter, Martha Rodriguez, Chitra Lalloo, Yukiko Kimura, Rob C. Fuhbrigge, Eleanor Pullenayegum, Megan L. Curran, Hernan Correa, Colleen K. Correll, Cassyanne L. Aguiar, Suzanne C. Li, Khaled Alsaeid, Laura Brungs, Tim Beukelman, Sampath Prahalad, Susan D. Thompson, Xiaohu Li, Brian Best, Tao Liu, Stacey M. Martinetti, Kevin W. Baszis, Alexis Boneparth, Monica Tsoras, Darshan H. Mehta, Anne M. Stevens, Annabelle N. Chua, Sangeeta Sule, Gretchen R. Heckel, Argerie Tsimicalis, Lucie Brosseau, Helen Bristow, Sarah Ringold, Thomas G. Mason, Mara L. Becker, Laura E. Schanberg, Ezra M. Cohen, Kaiyu Jiang, Yonit Sterba Ruas, Katie Stewart, Anne Dennos, Alexei A. Grom, Kalpana Manthiram, Yanmin Chen, Joshua Newsom, Peter R. Blier, Jennifer M. P. Woo, Lori B. Tucker, Michelle L. Dossett, Deirdre De Ranieri, Ginger Janow, Nicole Johnson, Hatice Ezgi Baris, Andrew H. Eichenfield, Laiping Wong, Pamela F. Weiss, Marisa S. Klein-Gitelman, Esi M. Morgan, Jennifer Stinson, Christian M. Hedrich, Ashlea Cook, Marsha M. Malloy, Megan Yuasa, M.S.C.E. Mara Becker M.D., Patrick J. McGrath, Max Shenberger, Beth Gottlieb, Daryl M. Okamura, Timothy Beukelman, Esra Meidan, Natasha M. Ruth, Lisha Zhu, Kazuo Yudoh, Kelly L. Mieszkalski, James A. Jegers, Mayumi Tamaki, Peter A. Nigrovic, Karen Onel, Christiaan Scott, Linda Wagner-Weiner, Kader Cetin Gedik, Ursula Range, Vikas R. Dharnidharka, Melissa S Tesher, Daniel J. Lovell, Jason Dare, Natalie J. Shiff, Karine Toupin April, Soko Setoguchi, Michael J. Buck, Yvonne C. Lee, Nadia Luca, Sarah Campillo, Suhas M. Radhakrishna, Lauren J. Lahey, Anna Carmela P. Sagcal-Gironella, Brandi Stevens, William H. Robinson, Hazim Alsaeed, Rachel Kaufmann, Anca D. Askanase, Stacy P. Ardoin, Egla Rabinovich, Paul Dancey, Kathryn S. Torok, Norm Ilowite, Elizabeth L. Roth-Wojcicki, Mario Medvedovic, Brian G. Leroux, Thomas A. Griffin, Megumi Tanaka, Richard K. Vehe, Lampros Fotis, Ronald M. Laxer, Salma Siddique, Joyce Hui-Yuen, Marilynn Punaro, Roberta A. Berard, Gabriele Hahn, Halima Moncrieffe, Kathryn M. Edwards, Dominic O. Co, Lauren Harris, Hannah Leahey, George Tomlinson, Maria Ibarra, Ciarán M. Duffy, Sarah Thomson, Jeremy Sokolove, Stacy Ardoin, Sandy D. Hong, Fatma Dedeoglu, Dustin J. Hahn, Nur Shaikh, Y. Ingrid Goh, Amir B. Orandi, Margalit Rosenkranz, Naweed Tajuddin, Elena Pope, Grendel Burrell, Shannon Carr, C. Egla Rabinovich, Jasim Alfailakawi, Roger Davis, Anabelle Chua, Toshiko Sato, Kathleen M. O'Neil, Anthony R. French, Lisa Imundo, Paula Morris, Joseph A Cafazzo, Maria F. Ibarra, Scott E. Wenderfer, Tamar Rubinstein, Danielle R. Bullock, Huan Xu, Joyce J. Hsu, Ritesh Korumilli, Hamid Alenezi, Julia Barsalou, John Matelski, Nicole Hershey, Heather Van Mater, Marsha Malloy, Lei Zhang, and Mark F. Bennett
- Subjects
030203 arthritis & rheumatology ,Pediatrics ,medicine.medical_specialty ,business.industry ,Norm (group) ,3. Good health ,03 medical and health sciences ,0302 clinical medicine ,Alliance ,Rheumatology ,Griffin ,Pediatrics, Perinatology and Child Health ,Immunology and Allergy ,Medicine ,030212 general & internal medicine ,business ,Humanities - Abstract
Author(s): Fotis, Lampros; Shaikh, Nur; Baszis, Kevin; French, Anthony; Tarr, Phillip; Grevich, Sriharsha; Lee, Peggy; Ringold, Sarah; Leroux, Brian; Leahey, Hannah; Yuasa, Megan; Foster, Jessica; Sokolove, Jeremy; Lahey, Lauren; Robinson, William; Newsom, Joshua; Stevens, Anne; Karasawa, Rie; Tamaki, Mayumi; Tanaka, Megumi; Sato, Toshiko; Yudoh, Kazuo; Jarvis, James N; Moncrieffe, Halima; Bennett, Mark F; Tsoras, Monica; Luyrink, Lorie; Xu, Huan; Prahalad, Sampath; Morris, Paula; Dare, Jason; Nigrovic, Peter A; Rosenkranz, Margalit; Becker, Mara; O’Neil, Kathleen M; Griffin, Thomas; Lovell, Daniel J; Grom, Alexei A; Medvedovic, Mario; Thompson, Susan D; Zhu, Lisha; Jiang, Kaiyu; Wong, Laiping; Buck, Michael J; Chen, Yanmin; Moncrieffe, Halima; Brungs, Laura; Liu, Tao; Wang, Ting; Jarvis, James N; Alsaeid, Khaled; Alfailakawi, Jasim; Alenezi, Hamid; Alsaeed, Hazim; Beukelman, Tim; Natter, Marc; Ilowite, Norm; Mieszkalski, Kelly; Burrell, Grendel; Best, Brian; Bristow, Helen; Carr, Shannon; Dennos, Anne; Kaufmann, Rachel; Kimura, Yukiko; Schanberg, Laura; Blier, Peter R; Boneparth, Alexis; Wenderfer, Scott E; Moorthy, L Nandini; Radhakrishna, Suhas M; Sagcal-Gironella, Anna Carmela P; von Scheven, Emily; Gedik, Kader Cetin; Siddique, Salma; Aguiar, Cassyanne L; Erkan, Doruk; Cohen, Ezra; Lee, Yvonne; Dossett, Michelle; Mehta, Darshan; Davis, Roger; Gilbert, Mileka; Goilav, Beatrice; Meidan, Esra
- Published
- 2016
44. Performance of a novel microarray multiplex PCR for the detection of 23 respiratory pathogens (SYMP-ARI study)
- Author
-
C. van de Sand, D. Neumann-Haefelin, Udo Kontny, Gerta Rücker, Valeria Falcone, Andreas Essig, Sibylle Bierbaum, Daniela Huzly, Martin Schumacher, Johannes Forster, Marcus Panning, K Blessing, Gernot Rohde, N. Besazza, N. Königsfeld, Reinhard Berner, Pulmonologie, and RS: NUTRIM - R3 - Chronic inflammatory disease and wasting
- Subjects
Adult ,Microbiology (medical) ,Influenza Virus ,medicine.medical_specialty ,Mycoplasma pneumoniae ,Atypical bacteria ,Microarray ,Concordance ,Biology ,medicine.disease_cause ,Sensitivity and Specificity ,Article ,Statistics, Nonparametric ,Young Adult ,Medical microbiology ,Nasopharynx ,Multiplex polymerase chain reaction ,Confidence Intervals ,medicine ,Humans ,Mycoplasma Pneumoniae ,Prospective Studies ,Monoplex ,Child ,Acute Respiratory Tract Infection ,Oligonucleotide Array Sequence Analysis ,Bacteria ,Infant ,Reproducibility of Results ,Bacterial Infections ,General Medicine ,Gold standard (test) ,biology.organism_classification ,Virology ,Molecular biology ,Nasopharyngeal Diseases ,Infectious Diseases ,Virus Diseases ,Child, Preschool ,Viruses ,Bordetella Pertussis ,Multiplex Polymerase Chain Reaction - Abstract
Symptoms of acute febrile respiratory tract infection are often unspecific, but the rapid identification of pathogens allows optimised patient management. The objective of this study was to evaluate a novel multiplex polymerase chain reaction (PCR) suspension microarray which detects 19 viral and four atypical bacterial targets. A comprehensive set of sensitive monoplex real-time PCR assays was used for each pathogen as the gold standard. A panel of archived as well as 300 prospectively collected clinical samples was analysed by both methods. At least one target was detected in 165/300 (55 %) samples by monoplex PCR and in 140/300 (46 %) samples by multiplex PCR, respectively. The positivity rate was significantly higher in paediatric patients compared to adults [126/154 (82 %) vs. 39/146 (27 %) by monoplex and 114/154 (74 %) vs. 26/146 (18 %) by multiplex PCR, respectively]. Among all samples, 17/300 (5.6 %) were positive for atypical bacteria by monoplex and 8/300 (2.6 %) by multiplex PCR, respectively. Multiple detections were recorded in 35/300 (11.6 %) samples by monoplex and 26/300 (8.7 %) by multiplex PCR. For the most common pathogens, the sensitivity ranged from 57 to 93 % and the specificity ranged from 95 to 100 %. The overall concordance between both methods was 77 % [95 % confidence interval (CI) 72-81 %]. False-negative results by multiplex PCR were mainly due to the low target concentration. Compared to monoplex PCR, the novel microarray assay proved its principle but displayed overall lower sensitivities, potentially restricting its use to paediatric patients. For some targets, only small numbers of positive samples were available, requiring larger studies to firmly assess the sensitivity and specificity.
- Published
- 2012
45. Significant decline in the erythromycin resistance of group A streptococcus isolates at a German paediatric tertiary care centre
- Author
-
Reinhard Berner, Philipp Henneke, Markus Hufnagel, and S. Farmand
- Subjects
Male ,Microbiology (medical) ,medicine.medical_specialty ,Cefotaxime ,Adolescent ,Streptococcus pyogenes ,Erythromycin ,Biology ,beta-Lactams ,Azithromycin ,medicine.disease_cause ,Group A ,Microbiology ,Medical microbiology ,Germany ,Streptococcal Infections ,Drug Resistance, Bacterial ,Prevalence ,medicine ,Humans ,Child ,Streptococcus ,Clindamycin ,Infant ,General Medicine ,Drug Utilization ,Anti-Bacterial Agents ,Penicillin ,Infectious Diseases ,Genes, Bacterial ,Child, Preschool ,Female ,Macrolides ,medicine.drug - Abstract
Group A streptococcus (GAS) is considered to be a major pathogen of bacterial tonsillopharyngitis in children. Although GAS is generally susceptible to penicillin, macrolides are often used as the second-line treatment. Over the last several decades, the rising macrolide resistance of GAS has been detected in several countries. With the current study, we aimed to determine the development of macrolide resistance at our paediatric centre. From March 2006 to May 2009, 350 GAS isolates were tested for susceptibility to erythromycin, azithromycin, clindamycin, penicillin and cefotaxime. Macrolide-resistant isolates were screened for the presence of genes related to macrolide resistance (mefA, ermB, ermTR, prtF1). In comparison to a prior study at our hospital, the erythromycin resistance rate decreased significantly from 13.6 to 2.6%. This effect may be attributable to a more restrictive use of macrolides in children in our region.
- Published
- 2011
46. Gruppe-A-Streptokokken-Infektionen im Kindesalter
- Author
-
Nicole Toepfner and Reinhard Berner
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,Pediatrics, Perinatology and Child Health ,medicine ,Surgery ,business - Abstract
Akute Halsschmerzen sind eine der haufigsten Ursachen fur kinder- und hausarztliche Konsultationen. In den meisten Fallen liegt eine virale Ursache zugrunde, aber auch bei einer GAS-Tonsillopharyngitis (GAS: Gruppe-A-Streptokokken) ist der Spontanverlauf gunstig. Um die bislang sehr haufige antibiotische Therapie bei Halsschmerzen zu begrenzen, wurde 2009 von der Deutschen Gesellschaft fur Allgemeinmedizin und Familienmedizin (DEGAM), der Deutschen Gesellschaft fur Kinder- und Jugendmedizin (DGKJ) und der Deutschen Gesellschaft fur Padiatrische Infektiologie (DGPI) eine Leitlinie Beratungsanlass: Halsschmerzen veroffentlicht. Nur bei ausgepragten Symptomen und dem hochgradigen klinischen Verdacht und – bei Kindern und Jugendlichen – dem Nachweis von GAS oder aber komplizierten Verlaufen wird heute eine antibiotische Therapie empfohlen. Die Indikation zur antibiotischen Therapie des klassischen Scharlachs, invasiver Infektionen oder Haut- und Weichteilinfektionen durch GAS andert sich durch die neue Leitlinie nicht.
- Published
- 2011
47. Wie viel Antibiotikum bei kindlicher Streptokokken-Tonsillitis?
- Author
-
Reinhard Berner
- Subjects
medicine.medical_specialty ,Otorhinolaryngology ,business.industry ,Head and neck surgery ,Medicine ,business ,Dermatology - Published
- 2018
48. Ulceroglandular tularemia in a toddler in Germany after a mosquito bite
- Author
-
Reinhard Berner, Christian von Schnakenburg, Joerg-Elard Otten, Wolf D. Splettstoesser, Annerose Serr, and C. A. Hanke
- Subjects
Male ,Mosquito bite ,Ulceroglandular tularemia ,Tularemia ,Germany ,medicine ,Animals ,Humans ,Serologic Tests ,Toddler ,Francisella tularensis ,biology ,Transmission (medicine) ,business.industry ,Infant ,Insect Bites and Stings ,bacterial infections and mycoses ,medicine.disease ,biology.organism_classification ,Virology ,Abscess ,Insect Vectors ,Culicidae ,Pediatrics, Perinatology and Child Health ,business ,Disease transmission ,Demography - Abstract
Although tularemia is a long-known disease, its significance had diminished over the last decades in Middle Europe. However, over the past years, there is new evidence suggesting that tularemia has re-emerged in Germany. In 2007, the highest number of human cases for almost 50 years has been notified. Beside typical vectors, new ways of transmission seem to gain significance. So far, mosquito bite-transmitted tularemia has only been known from Scandinavia but not from Middle Europe.We report the first case of a 1-year-old toddler from Southwestern Germany with mosquito bite-associated ulceroglandular tularaemia. The new and interesting features of this case are the young age of the patient and the unusual transmission route. The available data suggesting changes in the epidemiology for tularemia in Germany are reviewed. This is an interesting case of infantile tularemia with a very unusual transmission route, highlighting ongoing changes in the epidemiology of tularemia in Germany.
- Published
- 2009
49. Secular trends in pediatric bloodstream infections over a 20-year period at a tertiary care hospital in Germany
- Author
-
Reinhard Berner, Susanne Bartelt, Markus Hufnagel, Anita Burger, and Philipp Henneke
- Subjects
Staphylococcus aureus ,Pediatrics ,medicine.medical_specialty ,Neisseria meningitidis ,medicine.disease_cause ,Streptococcus agalactiae ,Sepsis ,Aminopenicillin ,Germany ,Drug Resistance, Bacterial ,Epidemiology ,medicine ,Humans ,Child ,Retrospective Studies ,Inpatients ,business.industry ,Mortality rate ,Incidence (epidemiology) ,Bacterial Infections ,medicine.disease ,Haemophilus influenzae ,Blood ,Mycoses ,Bacteremia ,Pediatrics, Perinatology and Child Health ,business - Abstract
Over the last 20 years, a number of medical innovations with impact on the incidence of bacterial and fungal bloodstream infections (BSIs) in children have been developed and implemented. Although appropriate empirical antimicrobial therapy is a prerequisite to the successful treatment of BSIs, to date, epidemiological data on long-term microbiological trends in BSIs of hospitalized children have not been available. Two cohorts of pediatric patients who were hospitalized in a single-center tertiary care hospital in Germany over a 20-year time span (period A from 1985 to 1995 vs. period B from 1997 to 2006) were retrospectively analyzed and compared with respect to the epidemiology and microbiology of BSIs. A total of 1,646 cases of monomicrobial BSIs were detected. The rate of positive blood culture results dropped from 4.5% in period A to 2.0% in period B. The proportion of gram-positive vs. gram-negative pathogens recovered from blood cultures remained stable. Among gram-positive pathogens, an increase in enterococci (3.3% vs. 8.2%) and in coagulase-negative staphylococci (CoNS) (22.9 vs. 28.2%) was observed. In contrast, BSIs caused by Staphylococcus aureus (16.4% vs. 11.7%), Streptococcus agalactiae (4.9% vs. 2.1%), Haemophilus influenzae (7.3% vs. 0.7%), and Neisseria meningitidis (1.9% vs. 0.5%) diminished. In analyzing subgroups, an increase of enterococcal and CoNS infections was noted among patients with immunosuppression and neonatal early-onset sepsis (EOS), while a decrease was found among late-onset sepsis (LOS) cases with S. viridans. Notably, aminopenicillin-resistant enterococci and aminopenicillin- and fluoroquinolone-resistant Enterobacteriaceae all increased over time, while the overall resistance pattern was still favorable. The overall mortality rate of BSIs decreased (5.2% vs. 2.6%). Over the 20-year study period, the spectrum of specific microorganisms among BSIs shifted, with opportunistic pathogens becoming predominant. Despite an increase in the proportion of antibiotic-resistant organisms, however, the mortality rate decreased.
- Published
- 2008
50. Ten years’ experience with year-round active surveillance of up to 19 respiratory pathogens in children
- Author
-
Claudius U. Meyer, Fred Zepp, Reinhard Berner, J. A. I. Weigl, Johannes Forster, Heinz J. Schmitt, and Wolfram Puppe
- Subjects
medicine.medical_specialty ,Pediatrics ,Population ,Population based ,Population-based ,Disease Outbreaks ,Germany ,medicine ,Humans ,Child ,education ,Respiratory Tract Infections ,Multiplex RT-PCR ,Original Paper ,education.field_of_study ,Surveillance ,business.industry ,Public health ,Infant, Newborn ,Infant ,Bacterial Infections ,Airway infections ,respiratory tract diseases ,Respiratory pathogens ,El Niño ,Virus Diseases ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Immunology ,Metapneumovirus ,Seasons ,Winter season ,business ,Sentinel Surveillance - Abstract
Introduction Surveillance systems for acute respiratory infections (ARI) in children currently are often limited in terms of the panel of pathogens and the age range investigated or are only syndromic and at times only active in the winter season. Methods Within PID-ARI.net, a research network for ARI in children in Germany, an active, year-round surveillance system was formed in three regions from north to south for population-based analysis. Children from birth to 16 years of age were included and up to 19 noncolonizing airway pathogens were tested for with multiplex RT-PCR. Results In the 10-year period from July 1996 to June 2006, a total of 18,899 samples were tested. The positive rate increased with the size of the test panel to up to 72.9%. Picornaviruses (35–39%), paramyxoviruses (23–28%) and orthomyxoviruses (5.8–12.5%) comprised the highest fraction. Reoviruses and Legionella pneumophila were not found at all and Chlamydia pneumoniae and Bordetella parapertussis only rarely. Respiratory syncytial virus and parainfluenza virus (PIV) type 3 were anticyclical in rhythmicity with metapneumovirus and PIV1 and PIV2. The age medians per pathogen depended predominantly upon the attack rate and interepidemic intervals. Conclusion Active surveillance systems for ARI are superior to passive systems. They should be pathogen-specific and comprehensive for viruses and bacteria and age ranges. They should be population-based and multilevel to avoid bias. The impact of atypical bacteria in children was highly overestimated in earlier studies.
- Published
- 2007
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.